In particular, Sakurai et al. showed that the inactivation of REV-7 in testicular germ cell tumors increased chemosensitivity to cisplatin and doxorubicin, by promoting DSB accumulation and apoptotic pathways, while it also recovered chemosensitivity in cisplatin-resistant cancer cells. The gene discussed is MAD2L2; the disease is cancer.